Adastra Holdings Ltd.
XTRX.CN
Canadian Securities Exchange0.20
CAD
- -
- -
Adastra Holdings Ltd.
XTRX.CN
(Canadian Securities Exchange)
Recent
price
0.20
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Adastra Holdings Ltd. (CSE: XTRX) engages in the extraction, processing, and manufacturing of cannabis concentrates and extracts for recreational and medical markets primarily in Canada. Founded in 2014 and headquartered in Langley, British Columbia, the company operates through its Health Canada-licensed facilities, including a 13,500 square foot standard processing plant co-located with its analytical testing lab, Chemia Analytics; it produces vape pens, wax, resin, infused pre-rolls, and other cannabis-derived products under its flagship brands Phyto Extractions and Endgame Extracts, which are distributed at over 2,000 retail locations nationwide, while also providing co-manufacturing services and turnkey processing solutions to licensed cultivators. In October 2025, Adastra completed the sale of its wholly-owned subsidiaries Adastra Labs Holdings (2019) Ltd., 1178562 B.C. Ltd., and Adastra Brands Inc. to 1538634 B.C. Ltd., enabling debt reduction and operational simplification through associated lease and intellectual property licensing agreements that preserve facility access and brand rights; the company also announced a record single purchase order exceeding $1 million and confirmed its current management team in January 2025. Adastra targets adult-use consumers, medical cannabis patients, and healthcare professionals, with segments in manufacturing and non-manufacturing operations such as PerceiveMD.